Cargando…

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Detalles Bibliográficos
Autores principales:	Anekpuritanang, Tauangtham, Klairmont, Matthew M., Gradowski, Joel, Hagiwara, Kohei, Bailey, Nathanael G., Chandra, Pranil, Liu, Yiwei, Mulder, Heather L., Easton, John, Zhang, Jinghui, Martin, Michael G., Owczarczyk, Anna B., Dunlap, Jennifer B., Fan, Guang, Press, Richard D., Raess, Philipp W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152993/ https://www.ncbi.nlm.nih.gov/pubmed/34559205 http://dx.doi.org/10.1182/bloodadvances.2021004983

Ejemplares similares

Notch Intracellular Domain (NICD) Expression and Clinical Manifestations of Second Primary Tumor at Esophagus in Patients with Head and Neck Squamous Cell Carcinoma
por: Anekpuritanang, Tauangtham, et al.
Publicado: (2019)

The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAF(V600E) Mutation
por: Anekpuritanang, Tauangtham, et al.
Publicado: (2021)

High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer
por: Korphaisarn, Krittiya, et al.
Publicado: (2019)

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
por: Dunlap, Jennifer B., et al.
Publicado: (2019)

NFE2L2 polymorphisms, mortality, and metabolism in the general population
por: Figarska, Sylwia M., et al.
Publicado: (2014)

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
por: Forcina, Giovanni C., et al.
Publicado: (2022)

Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
por: Yang, Xiaodong, et al.
Publicado: (2022)

Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto's Thyroiditis
por: Santos, Liliana R., et al.
Publicado: (2019)

Involvement of a Transcription factor, Nfe2, in Breast Cancer Metastasis to Bone
por: Zhang, Di, et al.
Publicado: (2020)

NFE2L1-mediated proteasome function protects from ferroptosis
por: Kotschi, Stefan, et al.
Publicado: (2022)

Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
por: Ji, Guiyi, et al.
Publicado: (2021)

Unravelling the role of NFE2L1 in stress responses and related diseases
por: Liu, Xingzhu, et al.
Publicado: (2023)

Prostatic adenocarcinoma oncocytic variant: Case report and literature review
por: Klairmont, Matthew M, et al.
Publicado: (2017)

Promoted adsorptive removal of chromium(vi) ions from water by a green-synthesized hybrid magnetic nanocomposite (NFe(3)O(4)Starch-Glu-NFe(3)O(4)ED)
por: Mahmoud, Mohamed E., et al.
Publicado: (2021)

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
por: von Otter, Malin, et al.
Publicado: (2010)

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
por: Gui, YaXing, et al.
Publicado: (2016)

Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases
por: Chandran, Aswathy, et al.
Publicado: (2023)

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
por: Elshani, Mustafa, et al.
Publicado: (2023)

Developmental Expression of the Nfe2-Related Factor (Nrf) Transcription Factor Family in the Zebrafish, Danio rerio
por: Williams, Larissa M., et al.
Publicado: (2013)

A Sarcoma at the Site of Previous Extravasation of Adriamycin
por: Ceulemans, Joris, et al.
Publicado: (2002)

APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2022)

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
por: Pajares, Marta, et al.
Publicado: (2016)

Concomitant constitutive LNK and NFE2 mutation with loss of sumoylation in a case of hereditary thrombocythemia
por: Böckelmann, Lukas Clemens, et al.
Publicado: (2021)

Effects of trehalose on NFE2L2, catalase, and superoxide dismutase in the kidney of aged rats
por: Hozhabri, Yaser, et al.
Publicado: (2022)

Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage
por: Gaastra, Ben, et al.
Publicado: (2022)

Hepatic Nfe2l2 Is Not an Essential Mediator of the Metabolic Phenotype Produced by Dietary Methionine Restriction
por: Fang, Han, et al.
Publicado: (2021)

The roles of NFE2L1 in adipocytes: Structural and mechanistic insight from cell and mouse models
por: Ren, Suping, et al.
Publicado: (2021)

Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer
por: Cuzziol, Caroline Izak, et al.
Publicado: (2022)

Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
por: Liu, Mengxiao, et al.
Publicado: (2022)

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent
por: Leonard, Jessica T., et al.
Publicado: (2016)

The Legionella pneumophila effector Lpg1137 is a homologue of mitochondrial SLC25 carrier proteins, not of known serine proteases
por: Gradowski, Marcin, et al.
Publicado: (2017)

A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas
por: Anderson, Sibyl E., et al.
Publicado: (2006)

Level and course of FEV(1 )in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
por: Siedlinski, Mateusz, et al.
Publicado: (2009)

Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2
por: Yue, Zhen, et al.
Publicado: (2015)

Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation
por: Wang, Xiaodong, et al.
Publicado: (2021)

Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas
por: Wang, Huabo, et al.
Publicado: (2021)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
por: Dai, Yue-chu, et al.
Publicado: (2021)

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
por: Jin, Xing, et al.
Publicado: (2021)

Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain
por: Li, Jian, et al.
Publicado: (2021)

Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming
por: Qiu, Lu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c1tsc3lt9e34g2mrnjk2jbhd9b